These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8885152)

  • 21. Are there options for donor-derived i.m. anti-D IgG preparations other than to prevent Rh(D) sensitization? The intravenous route.
    Rewald E
    Transfus Sci; 1995 Dec; 16(4):383-9. PubMed ID: 10159509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of anti-D (Rh) IgG or intramuscular polyvalent human immunoglobulin in the treatment of chronic autoimmune thrombocytopenic purpura].
    Vizcaíno G; Diez-Ewald M; Arteaga-Vizcaíno M; Torres E
    Invest Clin; 1992; 33(4):165-74. PubMed ID: 1338940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-D immunoglobulin in Rh(D) negative volunteers: clearance of Rh(D) positive red cells and kinetics of serum anti-D levels.
    Stucki M; Schnorf J; Hustinx H; Gerber H; Lerch PG; Halabi A; Kleinbloesem CH; Morell A
    Transfus Clin Biol; 1998 Jun; 5(3):180-8. PubMed ID: 9691361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-Rho(D) in two Rh-positive patients receiving kidney grafts from an Rh-immunized donor.
    Ramsey G; Israel L; Lindsay GD; Mayer TK; Nusbacher J
    Transplantation; 1986 Jan; 41(1):67-9. PubMed ID: 3001981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Adverse effects and patient information].
    Cortey A; Brossard Y
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S112-1S118. PubMed ID: 16495836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consensus Conference on Anti-D Prophylaxis. Edinburgh, United Kingdom, 8-9 April 1997. Papers and abstracts.
    Br J Obstet Gynaecol; 1998 Nov; 105 Suppl 18():iv, 1-44. PubMed ID: 10328662
    [No Abstract]   [Full Text] [Related]  

  • 27. Antenatal Rh immunoglobulin--help or hindrance?
    Pisciotto P; Gorbants I; Sundra M
    Transfusion; 1985; 25(1):88. PubMed ID: 2982225
    [No Abstract]   [Full Text] [Related]  

  • 28. Monoclonal anti-D for immunoprophylaxis.
    Scott ML
    Vox Sang; 2001 Nov; 81(4):213-8. PubMed ID: 11903995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prenatal immunoglobulin prevention in Rh(D)-negative nonsensitized pregnant women].
    Katsulov A
    Akush Ginekol (Sofiia); 1997; 36(2):1-2. PubMed ID: 9471891
    [No Abstract]   [Full Text] [Related]  

  • 30. Failures of intravenous Rh immune globulin prophylaxis: an analysis of the reasons for such failures.
    Bowman JM; Pollock JM
    Transfus Med Rev; 1987 Aug; 1(2):101-12. PubMed ID: 2856541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controversies in Rh prophylaxis. Who needs Rh immune globulin and when should it be given?
    Bowman JM
    Am J Obstet Gynecol; 1985 Feb; 151(3):289-94. PubMed ID: 2982267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunosuppressive protocols for transplantation and certain hematologic malignancies can prevent the primary immune response to the D blood group antigen.
    Seager A; Sandler SG
    Immunohematology; 2013; 29(3):110-4. PubMed ID: 24325172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expanded rhesus prophylaxis].
    Maroni ES
    Schweiz Rundsch Med Prax; 1987 Nov; 76(45):1254-9. PubMed ID: 2827286
    [No Abstract]   [Full Text] [Related]  

  • 34. Increases in anti-Rh(D) titre following pregnancy.
    Mollison PL
    Vox Sang; 1994; 67(3):326. PubMed ID: 7863638
    [No Abstract]   [Full Text] [Related]  

  • 35. Mechanism of anti-D-mediated immune suppression--a paradox awaiting resolution?
    Kumpel BM; Elson CJ
    Trends Immunol; 2001 Jan; 22(1):26-31. PubMed ID: 11286688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional in vivo characterization of human monoclonal anti-D in NOD-scid mice.
    Bazin R; Aubin E; Boyer L; St-Amour I; Roberge C; Lemieux R
    Blood; 2002 Feb; 99(4):1267-72. PubMed ID: 11830475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Transfusions of rhesus-incompatible platelet concentrates in Rouen University Hospital: procedures and consequences].
    Chamouni P; Josset V; Bastit D; Tavolacci MP; Lenain P; Varin R; Czernichow P
    Transfus Clin Biol; 2005 Oct; 12(4):306-12. PubMed ID: 16169273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Why women are not receiving anti-Rh prophylaxis.
    Hussey RM
    Br Med J (Clin Res Ed); 1987 Jan; 294(6564):119. PubMed ID: 3032323
    [No Abstract]   [Full Text] [Related]  

  • 39. A case for the antenatal administration of anti-D immunoglobulin to primigravidae.
    Tovey LA; Taverner JM
    Lancet; 1981 Apr; 1(8225):878-81. PubMed ID: 6112301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-D prophylaxis in 1997: the Edinburgh Consensus Statement.
    James D
    Arch Dis Child Fetal Neonatal Ed; 1998 May; 78(3):F161-3. PubMed ID: 9713023
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.